NPCE NASDAQ
Credit Risk of going bust: higher than 54% of companies Debt: 13.6% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.20 (down 98%), NeuroPace, Inc. would be worth roughly what it owes.
Total debt $69.9M against a stock market value of $445.9M.
Distance to default 4.77 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $29.5M (short-term plus half of long-term), stock volatility 59.4%; Altman Z -3.61. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Mountain View, CA 94043
US
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Morrell Martha | F-InKind | 335 | $13.97 | 2026-09-24 |
| Williams Patrick F. | F-InKind | 1,162 | $14.28 | 2026-09-20 |
| Becker Joel | F-InKind | 1,310 | $14.75 | 2026-09-03 |
| Morrell Martha | F-InKind | 358 | $14.13 | 2026-08-27 |
| Becker Joel | F-InKind | 1,126 | $14.13 | 2026-08-27 |